References of "RADERMECKER, Régis"
     in
Bookmark and Share    
Full Text
See detailLes PCSK9 : la mort des statines ?
RADERMECKER, Régis ULg

Conference (2016, March 19)

Detailed reference viewed: 24 (5 ULg)
Full Text
See detailDes nouvelles de votre revue
RADERMECKER, Régis ULg

in Revue de l'Association Belge du Diabète (2016), 59

Detailed reference viewed: 10 (1 ULg)
Full Text
See detailNos différences, une richesse
RADERMECKER, Régis ULg

in Revue de l'Association Belge du Diabète (2016), 59

Detailed reference viewed: 4 (0 ULg)
Full Text
See detailComme un air de rentrée
RADERMECKER, Régis ULg

in Revue de l'Association Belge du Diabète (2015), 58

Detailed reference viewed: 8 (1 ULg)
Full Text
See detailQuand le progrès doit rester humain
RADERMECKER, Régis ULg

in Revue de l'Association Belge du Diabète (2015), 58

Detailed reference viewed: 3 (0 ULg)
Full Text
Peer Reviewed
See detailAnalyse rétrospective des données concernant les patientes avec diabète gestationnel au CHU de Liège
RADERMECKER, Régis ULg; PHILIPS, Jean-Christophe ULg; Sepulchre, E

in Diabètes & Métabolism (2015, March), 41

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailRemboursement de la mesure continue du glucose en Belgique: un exemple de multidisciplinarité
RADERMECKER, Régis ULg; Contessi, El

in Diabètes & Métabolism (2015, March), 41

Detailed reference viewed: 19 (0 ULg)
Full Text
Peer Reviewed
See detailLa médecine personnalisée face à la médecine factuelle : aspects éthiques
RADERMECKER, Régis ULg

in Revue Médicale de Liège (2015), 70

More patients are actually treated due to the incredible improvements of medical care, especially in the field of pharmacotherapy. Medical guidelines are based on the results of controlled trials. This ... [more ▼]

More patients are actually treated due to the incredible improvements of medical care, especially in the field of pharmacotherapy. Medical guidelines are based on the results of controlled trials. This kind of medicine, also called Evidence Based Medicine, is actually the cornerstone of good clinical practice. Nevertheless, it remains a lot of patients disappointed by the fact that they have no medical gain of their treatment. The reason is that each patient has his own metabolic characteristics. Better is the characterization of such patients, better will be the treatment targeting for them. It is what is called the personalized medicine. To reach this challenge, it will appeal to the pharmacogenetic improvements. From an antagonism between EBM and personalized medicine, this new medical paradigm has to consider these approaches as partners. To reach this goal, medical doctors, legal authorities and pharmaceutical companies have to be responsible in front of these new ethics challenges. [less ▲]

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailSimultaneous determination of insulin and its analogues in pharmaceutical formulations by micellar electrokinetic chromatography
Lamalle, Caroline ULg; Servais, Anne-Catherine ULg; RADERMECKER, Régis ULg et al

in Journal of Pharmaceutical & Biomedical Analysis (2015)

A simple and efficient MEKC method was developed to simultaneously determine human insulin, its five analogues, the main degradation products and the excipients usually present in injection formulations ... [more ▼]

A simple and efficient MEKC method was developed to simultaneously determine human insulin, its five analogues, the main degradation products and the excipients usually present in injection formulations. A very fast method with a total analysis time of 3 min was then successfully validated for the analysis of human insulin and the quality control of different commercial formulations was carried out. [less ▲]

Detailed reference viewed: 59 (7 ULg)
Full Text
See detailQualités des soins diabétologiques et accessibilité aux soins: un bijou à préserver.
RADERMECKER, Régis ULg

in Revue de l'Association Belge du Diabète (2014), 57

Detailed reference viewed: 6 (0 ULg)
Full Text
See detailRemboursement de la mesure continue du glucose: du neuf.
RADERMECKER, Régis ULg

in Revue de l'Association Belge du Diabète (2014), 57

Detailed reference viewed: 7 (1 ULg)
Full Text
Peer Reviewed
See detailDépression et diabète de type 2. Analyse étiopathogènique d'une comorbidité fréquente
LUPPENS, David ULg; PIETTE, Catherine ULg; RADERMECKER, Régis ULg et al

in Revue Médicale de Liège (2014), 69(11), 611-617

Detailed reference viewed: 101 (21 ULg)
Full Text
Peer Reviewed
See detailEnquête concernant les connaissances de l'acido-cétose de patients de type 1 suivis dans la convention hospitalière du CHU de Liège
RADERMECKER, Régis ULg; Sepuchre, Edith; CONTESSI, Elide ULg

in La lettre des paramédicaux. SFD Paramédical. (2014), 60

Detailed reference viewed: 11 (1 ULg)
Full Text
See detailDe la différence naît la richesse
RADERMECKER, Régis ULg

in Revue de l'Association Belge du Diabète (2014), 57

Detailed reference viewed: 7 (0 ULg)
Full Text
See detailInformer et ne pas déformer
RADERMECKER, Régis ULg

in Revue de l'Association Belge du Diabète (2014), 57

Detailed reference viewed: 5 (0 ULg)
Full Text
See detailConnaître le passé pour appréhender l'avenir
RADERMECKER, Régis ULg

in Revue de l'Association Belge du Diabète (2014)

Detailed reference viewed: 8 (0 ULg)
Full Text
Peer Reviewed
See detailPompes à insuline, capteurs et activité physique. Existe t il des recommandations?
RADERMECKER, Régis ULg

in Diabète et Obésité (2014)

Detailed reference viewed: 42 (1 ULg)
Full Text
See detailLa voie du coeur
RADERMECKER, Régis ULg

in Revue de l'Association Belge du Diabète (2014), 57

Detailed reference viewed: 9 (0 ULg)
Full Text
See detailA propose d'un cas d'HbA1c indosable
RADERMECKER, Régis ULg

Scientific conference (2014, March)

Detailed reference viewed: 9 (1 ULg)